UNSTRUCTURED
Cancer is a complex genetic disease involving uncontrolled cell growth and proliferation, necessitating the effective targeting of dysregulated cellular pathways underlying cancer progression. Multiple genetic and epigenetic alterations characterize tumor progression and define the hallmarks of cancer. This may result in the dysregulation of growth factors, regulatory proteins, cell adhesion molecules, and immune system molecules driven by alterations in the expression profile of tumor suppressor genes and oncogenes, which may vary among different cancer types. Importantly, patients with the same cancer type respond differently to available cancer treatments, likely due to tumor-specific DNA, RNA, and proteins, indicating the need for patient-specific treatment options. Precision oncology has evolved as a form of cancer therapy that focuses on the genetic and molecular profiling of tumors to identify specific molecular alterations involved in carcinogenesis for tailored individualized cancer treatment. Advances in high-throughput technologies, including next-generation sequencing, have enabled gene expression profiling, providing detailed molecular characterization of various tumors. Moreover, the application of multiomic technologies, including genomics, proteomics, metabolomics, and single-cell multiomics, constitutes a novel approach for the identification and quantification of a comprehensive set of biological molecules to study their translation into cellular functions and tissue pathologies. The integration and analysis of various multiomic sequencing data are crucial in this regard, as they can reveal critical molecular changes, such as cancer-driving mutations, post-translational modifications, gene fusions, amplifications, and alterations in signaling networks within tumors. Furthermore, the role of computational techniques, such as artificial intelligence and deep learning, in analyzing complex data and identifying patterns of disease development for better outcomes, is now well established in precision medicine. Additionally, AI-powered multi-omics and network biology have been harnessed to integrate and analyze biological data through networks, which may prove crucial in solving key problems in precision oncology. This article aims to briefly explain the foundations and frontiers of precision oncology in the context of cutting-edge developments in tools and techniques associated with it and assess its scope and importance in achieving the intended goals over time.